Erik H.C.J. Buster

Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

Erik H.C.J. Buster, Hajo J. Flink, Yılmaz Çakaloğlu et al. · Gastroenterology · 2008 · 394 citations · Full text

Autoimmune Disease, Hbsag Loss, Peginterferon α-2B +4

Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

Erik H.C.J. Buster, Bettina E. Hansen, George Lau et al. · Gastroenterology · 2009 · 391 citations

Hepatic Disorders, Autoimmune Disease, Hepatology +9

Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B

Milan J. Sonneveld, Vincent Wai‐Sun Wong, Andrea M. Woltman et al. · Gastroenterology · 2011 · 165 citations · Full text

Hepatology, Autoimmune Disease, Polymorphisms Near Il28b +13

Peginterferon alpha‐2b is safe and effective in HBeAg‐positive chronic hepatitis B patients with advanced fibrosis† ‡ §

Erik H.C.J. Buster, Bettina E. Hansen, Jean Delwaide et al. · Hepatology · 2007 · 115 citations

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Erik H.C.J. Buster, Karel J. van Erpecum, Solko W. Schalm et al. · PubMed · 2008 · 58 citations